EXR
42
5
TXN
29
4
PHM
44
4
BK
60
2
CRM
65
6
PVH
58
5
AKAM
50
2
EXPD
29
2
ADP
57
2
AIZ
61
5
WMB
58
3
WHR
61
3
OKE
61
2
LB
16
9
DE
49
3
MDT
59
4
FMC
23
7
PFE
37
4
EW
55
5
KSS
36
2
EXR
42
5
TXN
29
4
PHM
44
4
BK
60
2
CRM
65
6
PVH
58
5
AKAM
50
2
EXPD
29
2
ADP
57
2
AIZ
61
5
WMB
58
3
WHR
61
3
OKE
61
2
LB
16
9
DE
49
3
MDT
59
4
FMC
23
7
PFE
37
4
EW
55
5
KSS
36
2
Financhill
Back

Cellectar Biosciences 10K Form

Sell
37

CLRB
Cellectar Biosciences

Last Price:
$0.24
Seasonality Move:
-2.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLRB News And Ratings

See the #1 stock for the next 7 days that we like better than CLRB

CLRB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-9.2M
Price / Cash Flow: 0
Annual Sales: $0.04
Price / Book: 6.26

Profitability

EPS (TTM): -1.90000
Net Income (TTM): $-50.1M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Cellectar Biosciences Earnings Forecast

Key Cellectar Biosciences Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 15 years.

Cellectar Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLRB
CUSIP: 15117F
Website: cellectar.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLRB Technical Analysis vs Fundamental Analysis

Sell
37
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy or a Sell?